[breadcrumb_custom]

Kezar Life Sciences Inc (KZR) Stock: A 52-Week Tale of Drops and Gains

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Kezar Life Sciences Inc’s current trading price is -86.92% away from its 52-week high, while its distance from the 52-week low is 30.45%. The stock’s price range during this period has varied between $0.67 and $6.73. The company, active in the Healthcare sector, saw a trading volume of around 1.89 million for the day, considerably higher average daily volume of 2.8 observed over the last three months.

Kezar Life Sciences Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $6.73 on 02/17/23, with the lowest value being $0.67 on 11/13/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

How Financial Performance Impacts Market Capitalization

Kezar Life Sciences Inc (KZR) has experienced a quarterly rise of 18.17% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 64.06M.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9061, with a change in price of -0.3100. Similarly, Kezar Life Sciences Inc recorded 640,631 in trading volume during the last 100 days, posting a change of -26.05%.

How KZR’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for KZR stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.08.

KZR Stock Stochastic Average

As of today, the raw stochastic average of Kezar Life Sciences Inc over the past 50 days is 41.03%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 41.03%. Additionally, the Stochastic %K and %D values for the company were 64.03% and 69.10%, respectively, over the past 20 days.

KZR Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -7.11% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -41.72%. Over the past 30 days, the price of KZR has leaped by -2.91%. And in the last five days, it has fallen by -5.73%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts